Virogin Biotech is an antineoplastic drug developer.
Virogin Biotech has raised $120.0M in total funding. The most recent round was Series D. The last funding was announced in September 2021.
Virogin Biotech's investors include Shenzhen Capital Group, CDH Investments, Korea Investment Partners, Pan-Lin Capital, China Merchants Venture Capital.
Virogin Biotech is headquartered in Vancouver, Canada.
Virogin Biotech is an antineoplastic drug developer.
Virogin Biotech is at the Series D stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Virogin Biotech — Funding & Investors." VCBacked, September 24, 2021, https://www.vcbacked.co/company/virogin-biotech. Accessed September 29, 2026.
VCBacked. (2021). Virogin Biotech — Funding & Investors. Retrieved September 29, 2026, from https://www.vcbacked.co/company/virogin-biotech
{{cite web |title=Virogin Biotech — Funding & Investors |url=https://www.vcbacked.co/company/virogin-biotech |website=VCBacked |access-date=September 29, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated